STL Volume 27 Number 5

3 POSTS 0 COMMENTS
Purchase PDF for $2.79
patient being examined by dermatologist

Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada

Results from multiple studies have shown promising response rates, and extracorporeal photopheresis has an overall excellent safety profile with very few adverse events reported.
image of doctor reading medical history of a patient, presumably Toxic Epidermal Necrolysis

Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches

Toxic epidermal necrolysis (TEN) is an immune-mediated, severe cutaneous adverse drug reaction characterized by epidermal detachment affecting greater than 30% body surface area.
image of pills and dermatologist examining patient's skin

Update on Drugs & Devices: September – October 2022

Update covering: Roflumilast cream 0.3% (Zoryve™), Ruxolitinib cream 1.5% (Opzelura™), HA-based dermal filler (Juvéderm® Volux™ XC), Abrocitinib tablets (Cinbinqo®), LetibotulinumtoxinA for injection (Letybo®), Berotralstat capsules (Orladeyo®), Mogamulizumab IV infusion (Poteligeo®), and Avacopan capsules (Tavneos®).

POPULAR

Advertisement